Page last updated: 2024-09-04

3-aminopyridine-1,n(6)-ethenoadenine dinucleotide phosphate and Dysmyelopoietic Syndromes

3-aminopyridine-1,n(6)-ethenoadenine dinucleotide phosphate has been researched along with Dysmyelopoietic Syndromes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, A; Fradin, Z; Mittelman, M; Redlich, O; Sokolover, N; Zeidman, A1

Other Studies

1 other study(ies) available for 3-aminopyridine-1,n(6)-ethenoadenine dinucleotide phosphate and Dysmyelopoietic Syndromes

ArticleYear
Platelet function and its clinical significance in the myelodysplastic syndromes.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:3

    Topics: Adenine Nucleotides; Adult; Aged; Aged, 80 and over; Arachidonic Acid; Blood Platelets; Collagen; Epinephrine; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Platelet Aggregation; Prognosis; Ristocetin

2004